Relevance of micrometastases detected by reverse transcriptase-polymerase chain reaction for melanoma recurrence: Systematic review and meta-analysis

Sao Paulo Medical Journal

Volumn 121, Issue 1, 2003, Pages 24-27

  da Silva, Allisson Monteiro ^a   de Oliveira Filho, Renato Santos ^a   Ferreira, Lydia Masako ^a   Saconato, Humberto ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Immunohistochemistry; Melanoma; Micrometastasis; Polymerase chain reaction; Reverse transcriptase; Sentinel node

Indexed keywords

ALPHA2B INTERFERON; EOSIN; HEMATOXYLIN; MESSENGER RNA;

CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; EMBASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDLINE; MELANOMA; META ANALYSIS; METASTASIS; MORBIDITY; PATIENT SELECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN CANCER; LYMPH NODE METASTASIS; METHODOLOGY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 0037604686     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802003000100006     Document Type: Review

References (26)

1. Brozena SJ, Fenske NA, Perez IR. Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin Surg Oncol 1993;9(3):165-7.
2. Oliveira Filho RS, Ferreira LM, Barbieri A, et al. Linfadenectomia seletiva com biópsia de linfonodo sentinela no melanoma cutâneo. Experiência brasileira - Projeto FAPESP 97/02516-0. An bras dermatol 2000;75:573-80.
3. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19(16):3622-34.
4. Heller R, Becker J, Wasselle J, et al. Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg 1991;126(12):1455-9.
5. Morton DL, Wen D, Cochran AJ. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy: An alternative to routine elective lymphadenectomy or "watch and wait". Surg Oncol Clin North Am 1992;1:247-59.
6. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127(4):392-9.
7. Smart KR, Cahoon BW, Dale PS. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma. Ann Surg 2000;66(3):280-3.
8. Messina JL, Glass LF, Cruse CW, Berman C, Ku NK, Reintgen DS. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999;23(6):686-90.
9. Wang X, Heller R, Van Voorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220(6):768-74.
10. Lukowsky A, Bellmann B, Ringk A, et al. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction. J Invest Dermatol 1999;113(4):554-9.
11. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, et al. Molecular test for the detection of tumor-cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149(3):759-64.
12. Keilholz U, Willhauck M, Rimoldi D, et al. Realiability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer 1998;34(5):750-3.
13. Goydos JS, Ravikumar TS, Germino FJ, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998;187(2):182-8.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
15. Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987;6(3):341-50.
16. The Nordic Cochrane Centre. Cochrane Collaboration. Review Manager. Powered by the Cochrane Collaboration. RevMan. Version 4.1-c. Available at http://www.cochrane-net.org/revman/.
17. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286-91.
18. Olsen O, Middleton P, Ezzo J, et al. Quality of Cochrane reviews: assessment of sample from 1998. BMJ 2001;323:829-32.
19. Joseph E, Messina J, Glass FL, et al. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am. 1997;3(6):341-5.
20. Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 1999;17(10):3238-44.
21. Blaheta HJ, Ellwanger U, Schittek B, et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J Invest Dermatol. 2000;114(4):637-42.
22. Li W, Stall A, Shivers SC, et al. Clinical relevance of molecular staging for melanoma comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 2000;231(6):795-803.
23. Blaheta HJ, Schittek B, Breuninger H, et al. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1992;23(7)822-8.
24. Pellegrino D, Bellina CR, Manca G, et al. Detection of melanoma cells in peripheral blood and sentinel lymph nodes by RT-PCR analysis: a comparative study with immunohistochemistry. Tumori 2000;86(4):336-8.
25. van der Velde-Zimmermann D, Schipper ME, de Weger RA, Hennipman A, Borel Rinkes IH. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol 2000;7(1):51-4.
26. McMasters KM. The Sunbelt Melanoma Trial. Ann Surg Oncol 2001;8(9Suppl):41S-43S.